India  

United States: Mintz IRA Update — Legal Challenges To The Medicare Drug Price Negotiation Program Continue - Mintz

Mondaq Monday, 4 March 2024
The IRA's Medicare Drug Price Negotiation Program (the "Negotiation Program" or "Program"), which aims to lower drug prices by enabling the federal government to negotiate prices...
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Latest Weight-Loss Drug Faces Shortages [Video]

Latest Weight-Loss Drug Faces Shortages

Latest Weight-Loss Drug , Faces Shortages . The United States Food and Drug Administration (FDA) says that high demand has left the latest weight-loss drug, Zepbound, in short supply. 'Newsweek'..

Credit: Wibbitz Top Stories     Duration: 01:30Published
CIA Attorneys Caution That Classified Information Should Not Be Attributed To The CIA [Video]

CIA Attorneys Caution That Classified Information Should Not Be Attributed To The CIA

The Committee Study of the Central Intelligence Agency's Detention and Interrogation Program is a report compiled by the bipartisan United States Senate Select Committee on Intelligence (SSCI)..

Credit: Rumble     Duration: 06:17Published
Drug Shortages Reach All-Time High in US, Pharmacists Say [Video]

Drug Shortages Reach All-Time High in US, Pharmacists Say

Drug Shortages Reach , All-Time High in US, , Pharmacists Say. According to the American Society of Health-System Pharmacists (ASHP) and the Utah Drug Information Service. the first quarter of 2024..

Credit: Wibbitz Top Stories     Duration: 01:31Published

Related news from verified sources

United States: Mintz IRA Update — Demystifying The IRA's Small Biotech Exception - Mintz

On August 29, 2023, CMS selected the first 10 high-expenditure, single source, Medicare Part D drugs subject to negotiation under the IRA's Medicare Drug Price...
Mondaq

United States: Mintz IRA Update — The IRA In 2024: The Medicare Drug Price Negotiation Program In Full Swing And Other Developments - Mintz

Our team's preparation for the year includes a review of the anticipated impact of the IRA on the health care industry in 2024.
Mondaq